Log on / register
Feedback | Support | My details
Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
Alao JP, Stavropoulou AV, Lam EW, Coombes RC, Vigushin DM
Mol Cancer 2006, 5:8
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Review    
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention
Alao JP
Molecular Cancer 2007, 6:24 (2 April 2007)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
2.


Commentary    
SCF Fbx4/alphaB-crystallin cyclin D1 ubiquitin ligase: a license to destroy
Barbash O, Lin DI, Diehl JA
Cell Division 2007, 2:2 (15 January 2007)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
3.


Review    
Epigenetic aberrations and cancer
Ducasse M, Brown MA
Molecular Cancer 2006, 5:60 (8 November 2006)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
4.


Short communication    
Role of glycogen synthase kinase 3 beta (GSK3) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells
Alao JP, Stavropoulou AV, Lam EWF, Coombes RC
Molecular Cancer 2006, 5:40 (3 October 2006)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]

This article is also cited by a further 2 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.